ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like Syndrome

NCT03747328 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped IND withdrawn

Conditions

Leigh Syndrome

Interventions

DRUG: ABI-009

Sponsor

Aadi Bioscience, Inc.